With a presence in over 140 countries, Servier combines a long-term vision with patient-focused research. Its journey in India emphasizes ethical, value-based innovation and the expansion of oncology care. India represents tremendous potential—not only as a market, but also as a partner for global manufacturing, R&D, and sustainable healthcare innovation.
Managing Director, Servier
Servier is an international, independent pharmaceutical group governed by a non-profit foundation, committed to therapeutic progress for the benefit of patients.
With our global headquarters in France, we operate in more than 140 countries and collaborate with 22, 000 employees worldwide.
Driven by a strong patient-centric mission, we focus our R&D efforts on four areas of excellence — oncology, immuno-inflammation, neuroscience and cardiovascular diseases — with oncology as a top strategic priority.
Our unique governance model enables us to reinvest a significant share of revenue into innovation and research every year, ensuring long-term vision and sustainability in serving patients and healthcare ecosystems.
Servier’s journey in India began in 1986 with a clear long-term objective: to become a trusted healthcare partner for Indian patients, healthcare professionals and the broader medical community.
Our entry strategy focused on three pillars — introducing globally proven therapies, building strong scientific engagement and shaping a local presence rooted in medical ethics and value-based innovation. This strategy has remained consistent over the decades as we continue to expand our portfolio and medical footprint across the country.
Over the past four decades, our development trajectory in India has been marked by key milestones:
Today, Servier India is recognized among the Great Place to Work in India laureates for five consecutive years. Moreover, this year we are recognized as one of the Best Workplaces in Asia, reflecting the strength of our people-first culture and our purposeful commitment to the medical and patient community.
India is one of the world’s most dynamic healthcare landscapes — combining scientific depth, rising digital health maturity and growing patient needs.
For Servier, India is not only a key market but a strategic growth engine for the region. We see a strong opportunity to accelerate access to innovative treatments, strengthen oncology care pathways and broaden our collaborations with hospitals, experts and research networks.
India’s vibrant talent pool, spirit of innovation and high medical standards make it a deeply promising ecosystem for long-term investment and partnerships. The country embodies both momentum and purpose — two values that resonate strongly with Servier and shape our long-term vision in India.
As a Conseiller du Commerce Extérieur de la France (CCEF), my role is to contribute to strengthening economic ties between France and India by sharing market insights, supporting French companies exploring opportunities in India and fostering bilateral collaboration.
In this role, I aim to:
Because the CCEF role is voluntary, it allows me to bring an independent, strategic-oriented perspective: bridging French industrial and innovation strengths with Indian growth opportunities and encouraging synergies that benefit both countries.
This responsibility resonates deeply with my personal and professional belief that India offers tremendous potential — not only as a market, but as a partner for global manufacturing, R&D and sustainable healthcare innovation.
I remain committed to helping French organizations approach India with realism, confidence and long-term strategic ambition, while contributing to France’s global economic influence through the lens of healthcare and life sciences.
For more information on this portrait or on UJA contact olivia@uja.in